Species |
Human |
Protein Construction |
TrkB/NTRK2 (Cys32-His430)_x000D_ Accession # AAH31835 |
His |
N-term |
C-term |
|
Purity |
> 95% as determined by BisTris PAGE > 95% as determined by HPLC |
Endotoxin Level |
Less than 1EU per μg by the LAL method. |
Biological Activity |
Measured by its binding ability in a functional ELISA. Immobilized Human/Murine/Rat BDNF, No Tag at 1μg/ml (100μl/well) on the plate can bind TrkB/NTRK2, His, Human. Test result was comparable to standard batch. |
Expression System |
HEK293 |
Theoretical Molecular Weight |
45.2 kDa |
Apparent Molecular Weight |
Due to glycosylation, the protein migrates to 65-80 kDa based on Bis-Tris PAGE result. |
Formulation |
Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). |
Reconstitution |
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
Storage & Stability |
Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
Target Background |
Neuron differentiation is likely regulated by a combination of transcription and growth factors. Embryonically, most geniculate neuron development is regulated by the growth factor brain derived neurotrophic factor (BDNF). BDNF expression becomes restricted to subpopulations of taste receptor cells with specific functions,the receptor for BDNF, tropomyosin kinase B receptor (TrkB), may also become developmentally restricted to a subset of taste neurons and could be one factor that is differentially expressed across taste neuron subsets. |
Synonyms |
GP145-TrkB; NTRK2; TRKB |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.